375 related articles for article (PubMed ID: 19463701)
1. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
[TBL] [Abstract][Full Text] [Related]
2. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
3. Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.
Oliveros A; Heckman MG; Del Pilar Corena-McLeod M; Williams K; Boules M; Richelson E
J Exp Biol; 2010 Dec; 213(Pt 24):4232-9. PubMed ID: 21113004
[TBL] [Abstract][Full Text] [Related]
4. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
Briody S; Boules M; Oliveros A; Fauq I; Richelson E
Behav Brain Res; 2010 Feb; 207(1):118-24. PubMed ID: 19800922
[TBL] [Abstract][Full Text] [Related]
5. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist.
Feifel D; Reza TL; Wustrow DJ; Davis MD
J Pharmacol Exp Ther; 1999 Feb; 288(2):710-3. PubMed ID: 9918579
[TBL] [Abstract][Full Text] [Related]
6. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
[TBL] [Abstract][Full Text] [Related]
8. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
9. Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats.
Uzbay T; Kayir H; Goktalay G; Yildirim M
J Psychopharmacol; 2010 Jun; 24(6):923-9. PubMed ID: 19282421
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the antidepressant mirtazapine on amphetamine- and dizocilpine-induced PPI deficits.
Larrauri JA; Levin ED
Pharmacol Biochem Behav; 2012 Jul; 102(1):82-7. PubMed ID: 22469866
[TBL] [Abstract][Full Text] [Related]
11. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
12. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
Schwabe K; Brosda J; Wegener N; Koch M
Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
[TBL] [Abstract][Full Text] [Related]
13. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
[TBL] [Abstract][Full Text] [Related]
14. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
Bakshi VP; Swerdlow NR; Geyer MA
J Pharmacol Exp Ther; 1994 Nov; 271(2):787-94. PubMed ID: 7965797
[TBL] [Abstract][Full Text] [Related]
15. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade.
Levin ED; Petro A; Caldwell DP
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):581-6. PubMed ID: 15866361
[TBL] [Abstract][Full Text] [Related]
16. Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain.
Wang R; Boules M; Gollatz E; Williams K; Tiner W; Richelson E
Brain Res Mol Brain Res; 2005 Jul; 138(1):24-34. PubMed ID: 15878217
[TBL] [Abstract][Full Text] [Related]
17. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
Levin R; Calzavara MB; Santos CM; Medrano WA; Niigaki ST; Abílio VC
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1748-52. PubMed ID: 21693159
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].
Suemaru K; Kohnomi S; Umeda K; Araki H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):121-6. PubMed ID: 18646597
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme (ACE) interacts with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice.
van den Buuse M; Zheng TW; Walker LL; Denton DA
Neurosci Lett; 2005 May 20-27; 380(1-2):6-11. PubMed ID: 15854741
[TBL] [Abstract][Full Text] [Related]
20. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
